Results 91 to 100 of about 231,116 (154)

Gastric cancer surgery in the era of neoadjuvant immunotherapy. [PDF]

Chin J Cancer Res
Ji J, Ji K, Su H.
europepmc   +1 more source

Navigating the immunosuppressive abyss: current hurdles and innovative breakthroughs in neoadjuvant immunotherapy for osteosarcoma. [PDF]

Front Immunol
Chen G, Hu M, Li Z, Yang K, Chen B, Xu T.   +5 more
europepmc   +1 more source

Image_1_Evaluation of neoadjuvant immunotherapy in resectable gastric/gastroesophageal junction tumors: a meta-analysis and systematic review.tif

BackgroundNeoadjuvant therapy for resectable gastric cancer/gastroesophageal junction tumors is progressing slowly. Although immunotherapy for advanced gastric cancer/gastroesophageal junction tumors has made great progress, the efficacy and safety of ...
Zhengxiao Zhang (9260121), Guangxin Zhang (107025), Haiping Guo (292959), Yinghao Zhao (739173), Chengyan Jin (3993488), Xueying Liu (344877), Jindong Li (534123), Ti Tong (4333033), Jincheng Wang (257684)   +8 more
core   +1 more source

Bridging the gap: modern pharyngolaryngoesophagectomy techniques and the rise of neoadjuvant/immunotherapy approaches. [PDF]

World J Surg Oncol
Nteka F, Triantafyllou T, Rouvelas I, Gkoutziotis I, Sakarellos P, Tolia M, Karavokyros I, Mpallas K, Schizas D.   +8 more
europepmc   +1 more source

Image_5_Evaluation of neoadjuvant immunotherapy in resectable gastric/gastroesophageal junction tumors: a meta-analysis and systematic review.tif

BackgroundNeoadjuvant therapy for resectable gastric cancer/gastroesophageal junction tumors is progressing slowly. Although immunotherapy for advanced gastric cancer/gastroesophageal junction tumors has made great progress, the efficacy and safety of ...
Zhengxiao Zhang (9260121), Guangxin Zhang (107025), Haiping Guo (292959), Yinghao Zhao (739173), Chengyan Jin (3993488), Xueying Liu (344877), Jindong Li (534123), Ti Tong (4333033), Jincheng Wang (257684)   +8 more
core   +1 more source

MRI-guided risk stratification for neoadjuvant immunotherapy in rectal cancer. [PDF]

Front Immunol
Zhang J, Tian F, Shang Y, Dai H, Zhang S, Kang B, Xin J, Wang X, Jing C, Sun C.   +9 more
europepmc   +1 more source

Reconsidering Surgical Strategy in the Era of Neoadjuvant Immunotherapy for Head and Neck Cancer. [PDF]

Otolaryngol Head Neck Surg
Migliorelli A, Sacchetto A, Patel S.
europepmc   +1 more source

Optimizing patient selection for neoadjuvant immunotherapy in gastric cancer via pre-treatment imaging analysis. [PDF]

Front Immunol
Zhang HX, Huang ZN, Chen QX, Wang L, Chen F, Weng CM, Li YF, Li Y, Liu ZW, Chen JQ, Chen QY, Wang JB, Li P, Zheng CH, Huang CM, Wang B, Cai LS, Lin JX, Xie JW.   +18 more
europepmc   +1 more source

Biomarker-driven neoadjuvant immunotherapy in triple-negative breast cancer: emerging therapeutic targets FOXP3 and WT1. [PDF]

Front Immunol
Zhang Z, Zhao R, Hu Y, Xie Q, Yu Y, Li K, Ding Z, Wang M.   +7 more
europepmc   +1 more source

Less is more: A single-dose, non-waiting neoadjuvant immunotherapy strategy for hepatocellular carcinoma. [PDF]

Biomed J
Chen KK, Lin TJ, Su TW, Chen PD, Ho MC, Wu YM, Shen YC, Cheng AL.   +7 more
europepmc   +1 more source